Brand Name | Status | Last Update |
---|---|---|
2 pack assured instant hand sanitizer with moisturizers (vitamin e and aloe) | OTC monograph not final | 2014-11-02 |
25 person ansi | OTC monograph final | 2010-06-07 |
3 hand sanitizers | OTC monograph not final | 2014-11-15 |
3 pack assured instant hand sanitizer with moisturizers (vitamin e and aloe) | OTC monograph not final | 2014-11-02 |
3 pack assured instant hand sanitizer with moisturizers (vitamin e and moisturizers) | OTC monograph not final | 2014-11-02 |
3 pack family dollar instant hand sanitizers | OTC monograph not final | 2014-11-28 |
50 person ansi | OTC monograph final | 2010-06-07 |
7-11 instant hand sanitizer with aloe and vitamin e | OTC monograph not final | 2011-11-02 |
a and d | OTC monograph final | 2020-01-07 |
a and d plus e | C200263 | 2024-08-08 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 8 | 3 | 6 | 3 | 19 |
Fatty liver | D005234 | EFO_0003934 | — | 1 | 8 | 2 | 6 | 3 | 19 |
Liver diseases | D008107 | HP_0002910 | K70-K77 | 1 | 5 | 1 | 4 | 1 | 11 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 1 | 2 | 1 | 2 | 6 | 11 |
Obesity | D009765 | EFO_0001073 | E66.9 | 1 | 1 | 1 | 2 | 3 | 8 |
Oxidative stress | D018384 | EFO_1001905 | — | — | 2 | — | 1 | 5 | 8 |
Inflammation | D007249 | MP_0001845 | — | — | 2 | 1 | 1 | 4 | 7 |
Wounds and injuries | D014947 | — | T14.8 | — | 2 | — | 1 | 1 | 4 |
Osteoradionecrosis | D010025 | EFO_1001821 | — | — | — | 1 | 1 | 2 | 4 |
Infections | D007239 | EFO_0000544 | — | — | — | 2 | 1 | 1 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Syndrome | D013577 | — | — | — | 6 | 4 | — | 6 | 15 |
Fibrosis | D005355 | — | — | 1 | 5 | 3 | — | — | 8 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.9 | — | 4 | 3 | — | 1 | 7 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | 1 | 1 | — | 3 | 6 |
Obstructive lung diseases | D008173 | HP_0006536 | — | 1 | 1 | 1 | — | 3 | 6 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | 1 | 3 | — | 1 | 6 |
Overweight | D050177 | — | E66.3 | — | 1 | 1 | — | 4 | 6 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 2 | 2 | — | 1 | 6 |
Osteonecrosis | D010020 | EFO_0004259 | M87 | — | 1 | 1 | — | 3 | 5 |
Prostatic neoplasms | D011471 | — | C61 | 1 | 1 | 2 | — | 1 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Anemia | D000740 | HP_0001903 | D64.9 | 2 | 2 | — | — | 3 | 6 |
Asthma | D001249 | EFO_0000270 | J45 | 3 | 2 | — | — | 1 | 6 |
Covid-19 | D000086382 | — | — | — | 2 | — | — | 3 | 5 |
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 2 | — | — | 2 | 4 |
Pneumonia | D011014 | EFO_0003106 | — | — | 2 | — | — | 1 | 3 |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 2 | — | — | 1 | 3 |
Mucositis | D052016 | EFO_1001898 | — | — | 1 | — | — | 2 | 3 |
Depression | D003863 | — | F33.9 | — | 1 | — | — | 2 | 3 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | — | 1 | — | — | 2 | 3 |
Acne vulgaris | D000152 | EFO_0003894 | L70 | — | 1 | — | — | 2 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 3 | — | — | — | 5 | 8 |
Iron deficiencies | D000090463 | — | — | 1 | — | — | — | 4 | 5 |
Heart failure | D006333 | HP_0001635 | I50 | 3 | — | — | — | 1 | 4 |
Iron-deficiency anemia | D018798 | HP_0001891 | D50 | 1 | — | — | — | 3 | 4 |
Allergic rhinitis | D065631 | — | J30.9 | 2 | — | — | — | 1 | 3 |
Rhinitis | D012220 | EFO_0008521 | J31 | 1 | — | — | — | 2 | 3 |
Hypertension | D006973 | EFO_0000537 | I10 | 1 | — | — | — | 1 | 2 |
Fatigue | D005221 | HP_0012378 | R53.83 | 1 | — | — | — | 1 | 2 |
Hypersensitivity | D006967 | HP_0012393 | T78.40 | 1 | — | — | — | 1 | 2 |
Pulmonary arterial hypertension | D000081029 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alopecia areata | D000506 | EFO_0004192 | L63 | — | — | — | — | 4 | 4 |
Alopecia | D000505 | HP_0002293 | L64 | — | — | — | — | 4 | 4 |
Hypotrichosis | D007039 | HP_0008070 | — | — | — | — | — | 4 | 4 |
Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | — | 3 | 3 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 3 | 3 |
Skin aging | D015595 | EFO_0005422 | — | — | — | — | — | 3 | 3 |
Myalgia | D063806 | HP_0003326 | M79.1 | — | — | — | — | 2 | 2 |
Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | — | — | — | — | 2 | 2 |
Thalassemia | D013789 | EFO_1001996 | D56 | — | — | — | — | 2 | 2 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 2 | 2 |
Drug common name | Vitamin e |
INN | phytomenadione |
Description | (R,R,R)-alpha-tocopherol is an alpha-tocopherol that has R,R,R configuration. The naturally occurring stereoisomer of alpha-tocopherol, it is found particularly in sunflower and olive oils. It has a role as an antioxidant, a nutraceutical, an antiatherogenic agent, an EC 2.7.11.13 (protein kinase C) inhibitor, an anticoagulant, an immunomodulator, an antiviral agent, a micronutrient, an algal metabolite and a plant metabolite. It is an enantiomer of a (S,S,S)-alpha-tocopherol. |
Classification | Unknown |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 10191-41-0 |
RxCUI | — |
ChEMBL ID | CHEMBL3989727 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | A034SE7857 (ChemIDplus, GSRS) |